| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
37,090,000 |
| Market
Cap: |
25.96(M) |
| Last
Volume: |
1,764,528 |
Avg
Vol: |
1,759,711 |
| 52
Week Range: |
$0.439 - $1.6 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viracta Therapeutics is a precision oncology company focused on the development of medicines targeting virus-associated malignancies. Co.'s main program is focused on cancers associated with the Epstein-Barr virus (EBV). Co.'s main product candidate is an all-oral combination therapy of its investigational drug, nanatinostat and the antiviral agent valganciclovir (collectively referred to as Nana-val). Nana-val is being investigated in clinical trials, including NAVAL-1, a trial for the treatment of multiple subtypes of relapsed/refractory EBV-positive (EBV+) lymphoma, as well as a trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
100,000 |
100,000 |
| Total Buy Value |
$0 |
$0 |
$49,361 |
$49,361 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
2 |
| Total Shares Sold |
0 |
3,405 |
10,637 |
44,899 |
| Total Sell Value |
$0 |
$2,493 |
$9,445 |
$116,762 |
| Total People Sold |
0 |
1 |
1 |
3 |
| Total Sell Transactions |
0 |
1 |
3 |
11 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hurwitz Edward |
Director |
– • – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,997,470 |
381,683 |
|
- |
|
| Hurwitz Edward |
Director |
– • – |
2010-06-30 |
4 |
A |
$0.28 |
$3,275,862 |
I/I |
11,912,224 |
268,883 |
|
- |
|
| Kerins Patrick J |
10% Owner |
– – • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,994,990 |
33,819,441 |
|
- |
|
| Kerins Patrick J |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
I/I |
23,824,451 |
23,824,451 |
1.5 |
- |
|
| Drant Ryan D |
10% Owner |
– – • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,994,990 |
38,819,441 |
|
- |
|
| Drant Ryan D |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
I/I |
23,824,451 |
23,824,451 |
1.5 |
- |
|
| Kolluri Krishna Kittu |
10% Owner |
– – • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,994,990 |
33,819,441 |
|
- |
|
| Kolluri Krishna Kittu |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
I/I |
23,824,451 |
23,824,451 |
1.5 |
- |
|
| Baskett Forest |
10% Owner |
– – • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,994,990 |
33,819,441 |
|
- |
|
| Baskett Forest |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
I/I |
23,824,451 |
23,824,451 |
1.5 |
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,994,990 |
33,819,441 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
D/D |
23,824,451 |
23,824,451 |
2.45 |
- |
|
| Bay City Capital Fund V Co-Investment Fund Lp |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
D/D |
23,824,450 |
632,416 |
2.45 |
- |
|
| Bay City Capital Fund V Co-Investment Fund Lp |
10% Owner |
– – • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
9,994,990 |
186,900 |
|
- |
|
| Misfeldt Dayton |
Director |
– • • |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
9,994,990 |
632,416 |
|
- |
|
| Misfeldt Dayton |
Director |
– • • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
I/I |
23,824,450 |
445,516 |
2.25 |
- |
|
| Ketchum Steven B |
Sr. Vice President, R & D |
• – – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
99,940 |
340,535 |
|
- |
|
| Ketchum Steven B |
Sr. Vice President, R & D |
• – – |
2010-06-30 |
4 |
B |
$0.28 |
$65,517 |
D/D |
238,243 |
240,595 |
2.74 |
- |
|
| Bjerkholt Eric |
Sr. VP, CFO & Corp. Secretary |
• – – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
99,940 |
338,183 |
|
- |
|
| Bjerkholt Eric |
Sr. VP, CFO & Corp. Secretary |
• – – |
2010-06-30 |
4 |
B |
$0.28 |
$65,517 |
I/I |
238,243 |
238,243 |
1.99 |
- |
|
| Swisher Daniel N Jr |
President and CEO |
• • – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
199,890 |
676,377 |
|
- |
|
| Swisher Daniel N Jr |
President and CEO |
• • – |
2010-06-30 |
4 |
B |
$0.28 |
$131,034 |
I/I |
476,487 |
476,487 |
2.66 |
- |
|
| Semon Dominique |
10% Owner |
– – • |
2010-04-30 |
4 |
S |
$0.98 |
$373,820 |
I/I |
(382,542) |
3,921,095 |
|
- |
|
| Semon Dominique |
10% Owner |
– – • |
2010-04-30 |
4 |
OE |
$0.22 |
$374 |
I/I |
1,699 |
4,303,637 |
|
- |
|
| Semon Dominique |
10% Owner |
– – • |
2010-02-25 |
4 |
S |
$0.94 |
$747,604 |
I/I |
(793,803) |
2,604,497 |
|
- |
|
276 Records found
|
|
Page 9 of 12 |
|
|
0.01 (1.43%) 
